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Abstract 
Background 
Asthma is a frequent chronic inflammatory disease of the airways, and the assessment of 
health-related quality of life (HrQoL) is important in both research and routine care. Various 
asthma-specific measures of HrQoL exist but there is uncertainty which measures are best 
suited for use in research and routine care. Therefore, the aim of the proposed research is a 
comprehensive systematic assessment of the measurement properties of the existing measures 
that were developed to measure asthma-specific quality of life. 
Methods/design 
This study is a systematic review of the measurement properties of asthma-specific measures 
of health-related quality of life. PubMed and Embase will be searched using a selection of 
relevant search terms. Eligible studies will be primary empirical studies evaluating, 
describing or comparing measurement properties of asthma-specific HRQL tools. Eligibility 
assessment and data abstraction will be performed independently by two reviewers. Evidence 
tables will be generated for study characteristics, instrument characteristics, measurement 
properties and interpretability. The quality of the measurement properties will be assessed 
using predefined criteria. Methodological quality of studies will be assessed using the 
COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) 
checklist. A best evidence synthesis will be undertaken if more than one study have 
investigated a particular measurement property. 
Discussion 
The proposed systematic review will produce a comprehensive assessment of measurement 
properties of existing measures of asthma-specific health-related quality of life. We also aim 
to derive recommendations in order to help researchers and practitioners alike in the choice of 
instrument. 
Trial registration 
PROSPERO registration number: CRD42014010491. 
http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014010491 
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Background 
Asthma is a chronic inflammatory disease with variable airway obstruction, characterized by 
episodes of coughing, wheezing, breathlessness and chest tightness. It is estimated that 
around 300 million people worldwide suffer from asthma and that globally asthma accounts 
for about one in every 250 deaths [1]. By 2025, there may be 100 million more people with 
asthma. The number of disability-adjusted life years (DALYs) lost to asthma is comparable to 
the DALYs lost for diabetes, cirrhosis of the liver or schizophrenia. 
Various medical and non-medical interventions exist to alleviate asthma, many of which have 
been assessed in randomized controlled trials. Because different outcome measures of various 
domains (such as disease severity, quality of life, symptoms) are used in different trials, the 
findings from these trials are difficult to compare. The lack of standardized asthma outcome 
measurement currently makes truly evidence-based decision making difficult, if not 
impossible. 
One frequently used outcome is ‘health-related quality of life’ (HRQoL) which is a patient-
reported outcome (PRO). According to the definition of the U.S. Food and Drug 
Administration (FDA), a PRO is defined as ‘any report of the status of a patient's health 
condition that comes directly from the patient, without interpretation of the patient's 
responses by a physician or anyone else’ [2]. Several reviews of PRO instruments for asthma 
have been conducted. 
A published structured review identified six common asthma-specific quality-of-life 
measures: the Juniper Asthma Quality of Life Questionnaire (AQLQ-J) [3], the Sydney 
Asthma Quality of Life Questionnaire (AQLQ-S) [4], the Living with Asthma Questionnaire 
(LWAQ) [5], the St George's Respiratory Questionnaire (SGRQ) [6,7], the Quality of Life for 
Respiratory Illness Questionnaire (QOL-RIQ) [8] and the Rhinasthma questionnaire [9]. The 
measures were reviewed using seven different criteria: conceptual and measurement model, 
reliability, validity, interpretability, burden, administration format and translations. The 
review concluded that the instruments differed in almost all criteria, and therefore, it cannot 
be assumed that they measure the same thing. The authors recommend to select those 
questionnaires that were designed for asthma and that do not assess symptoms as part of 
quality of life (QoL). These requirements are fulfilled by the Sydney Asthma QoL 
Questionnaire (AQLQ-S) [4] and the Living with Asthma Questionnaire (LWAQ) [5]. 
However, it is also stated that it remains unclear which of the questionnaires best reflects 
patient perception of QoL. 
The Patient-reported Outcome Measurement Group (POMG) in England completed a 
comprehensive structured review of patient-reported outcome measures for people with 
asthma and provided recommendations to the Department of Health [10]. The difference to 
the structured review is that it not only encompasses asthma-specific quality-of-life measures, 
but also measures of health status, asthma control, utilities and symptoms. Twenty-two 
asthma-specific measures were evaluated. Based on the volume of evaluations and good 
measurement and operational characteristics, the original Juniper Asthma Quality of Life 
Questionnaire [3], the standardized Juniper Asthma Quality of Life Questionnaire [11] and 
the mini Juniper Asthma Quality of Life Questionnaire [12] as well as the Sydney Asthma 
Quality of Life Questionnaire [4] were presented to a multidisciplinary panel for discussion. 
Based on appraisal of evidence by the POMG and taking account of ratings and comments 
from the panel, the mini AQLQ was recommended as an asthma-specific instrument. Its ease 
of use and patient acceptability as well as the good concordance between postal and 
supervised administration was considered to be an important characteristic for measuring 
outcomes in NHS clinical care. 
The third important review comes from the USA. In the light of a lack of adequate outcomes 
standardization, several National Institutes of Health (NIH) organizations that support asthma 
research as well as the Agency for Healthcare Research and Quality in the US agreed to a 
drive towards outcome standardization. As part of this effort, the published documentation 
relating to asthma-specific quality-of-life measures was reviewed [13]. In the review, the 
existing instruments were classified as follows: 
• Core outcomes: selective set of asthma outcomes to be considered by participating NIH 
institutes and other federal agencies as requirements for institute-/agency-initiated funding 
of clinical trials and large observational studies in asthma 
 
• Supplemental outcomes: asthma outcomes for which standard definitions can or have been 
developed, methods for measurement can be specified, and validity has been proved but 
whose inclusion in funded clinical asthma research will be optional 
 
• Emerging outcomes: asthma outcomes that have the potential to (1) expand and/or 
improve current aspects of disease monitoring and (2) improve translation of basic and 
animal model-based asthma research into clinical research. Emerging outcomes may be 
new or may have been previously used in asthma clinical research, but they are not yet 
standardized and require further development and validation 
The US review identified 11 instruments for adults, the ABP [14], the Asthma Impact Survey 
[15], the AQLQ-J-s [11], the mini AQLQ-J [12], the LWAQ [16], the modified AQLQ-S 
[17], the Asthma Short Form [18], the SGRQ [6,7] and the AQ-20 [17]. 
None of these qualified as core outcome because they predominantly measured indicators of 
asthma control (symptoms and/or functional status), failed to provide a distinct, reliable score 
measuring all key dimensions of the intended construct and/or lacked adequate psychometric 
data. 
All three reviews have failed to perform a systematic literature search and have not included 
a systematic assessment of the methodological quality of the included studies. The proposed 
review will therefore systematically assess the measurement properties of asthma-specific 
quality-of-life measures and include an assessment of the methodological quality of all 
included studies. 
Methods/design 
This study is a systematic review of the measurement properties of asthma-specific measures 
of health-related quality of life. 
Eligible measures 
All measures which are specifically designed to measure health-related quality of life in 
asthma are eligible. 
Eligible studies 
Inclusion criteria 
A study will be included if it is a full text paper, published in English and describes the 
development (‘inauguration paper’) and/or evaluation of the measurement properties 
(‘validation paper’) of an asthma-specific measure of HRQoL. The study population should 
be adults (≥18 years) with asthma. The study should be published as a full text paper and the 
instrument should be a self-report questionnaire. 
Exclusion criteria: Articles reporting on interview instruments or instruments for proxies will 
not be considered for the purpose of this review. Articles that report an eligible measure, e.g. 
as an outcome in a clinical trial without any explicit validation will not be considered eligible. 
Literature search 
A systematic literature search will be performed in PubMed and EMBASE. Blocks of search 
terms will be used relating to the following aspects: 
• Construct of interest (asthma-specific health-related quality of life): here, the broad search 
term ‘quality of life’ will be used. 
 
• Target population (adult asthma patients): here, different combinations will be used like 
‘allergic’ or ‘atopic’ or ‘bronchial’ and each will be combined with ‘asthma’. The search 
will be limited to humans. 
 
• Measurement properties: The highly sensitive PubMed search filter for finding studies on 
measurement properties developed by Terwee et al. will be used to identify relevant 
articles [19]. This filter has a sensitivity of 97.4 % and a precision of 4.4 %. A selection of 
relevant search terms will be used in EMBASE, which has been used before in reviews. 
For each of these search strategies, a thorough list of synonyms will be collated using index 
terms (e.g. MESH terms in PubMed) linked with other free text words. The synonyms will be 
combined with the conjunction ‘OR’. After that, the searches designed according to the three 
main aspects will be combined with ‘AND’ in order to get to the list of publications from 
which the relevant ones will be picked. A further search will be conducted with the names of 
instruments found in the original search. These names should be combined with AND with 
the requirements for the target population and measurement properties. The references of all 
the included relevant articles will also be screened. In addition, websites of relevant 
professional organizations and institutions will be searched. For all searches, search dates will 
be provided in the review. 
Study selection 
In a first phase, titles and abstracts will be assessed for eligibility. Full text articles will be 
obtained for the remaining abstracts and again be assessed for eligibility. Each citation will 
be judged for eligibility independently by two reviewers. Disagreements will be resolved by 
discussion of all reviewers. 
Data extraction 
Two reviewers will independently extract data from each article included. Relevant data from 
all included articles will be summarized in evidence tables. Evidence tables will contain the 
following information: characteristics of the instrument (name of measure, domains 
measured, number of items), characteristics of the study population (geographical location, 
gender, age, co-morbidities), results for conceptual models and measurement properties 
(reliability, validity, responsiveness to change according to Table 1) and results for 
interpretability (including minimal important difference). The evidence tables will be pilot-
tested. 
Table 1 Quality criteria for measurement properties 
Property Rating Quality criteria 
Reliability   
     Internal 
consistency 
+ (Sub)scale unidimensional AND Cronbach's alpha(s) ≥0.70 
? 
− Dimensionality not known OR Cronbach's alpha not determined 
(Sub)scale not unidimensional OR Cronbach's alpha(s) <0.70 
     Measurement error + MIC > SDC OR MIC outside the LOA 
? MIC not defined 
− MIC ≤ SDC OR MIC equals or inside LOA 
     Reliability + ICC/weighted kappa ≥0.70 OR Pearson's r ≥ 0.80 
? Neither ICC/weighted kappa, nor Pearson's r determined 
− ICC/weighted kappa <0.70 OR Pearson's r < 0.80 
Validity   
     Content validity + All items are considered to be relevant for the construct to be 
measured, for the target population and for the purpose of the 
measurement AND the questionnaire is considered to be 
comprehensive 
? Not enough information available 
− Not all items are considered to be relevant for the construct to be 
measured, for the target population and for the purpose of the 
measurement OR the questionnaire is considered not to be 
comprehensive 
Construct validity   
     Structural validity + Factors should explain at least 50 % of the variance 
? Explained variance not mentioned 
− Factors explain <50 % of the variance 
     Hypothesis testing + Correlation with an instrument measuring the same construct ≥0.50 OR 
at least 75 % of the results are in accordance with the hypotheses AND 
correlation with related constructs is higher than with unrelated 
constructs 
? Solely correlations determined with unrelated constructs 
− Correlation with an instrument measuring the same construct <0.50 OR 
<75 % of the results are in accordance with the hypotheses OR 
correlations with related constructs are lower than with unrelated 
constructs 
Responsiveness   
     Responsiveness + Correlation with changes on instruments measuring the same construct 
≥0.50 OR at least 75 % of the results are in accordance with the 
hypotheses OR AUC ≥0.70 AND correlation with changes in related 
constructs are higher than with unrelated constructs 
? Solely correlations determined with unrelated constructs 
− Correlations with changes on instruments measuring the same construct 
<0.50 OR <75 % of the results are in accordance with the hypotheses 
OR AUC <0.70 OR correlations with changes in related constructs are 
lower than with unrelated constructs 
Plus sign indicates positive rating; question mark, indeterminate rating and minus sign, negative rating. 
MIC minimal important change, SDC smallest detectable change, LOA limits of agreement, ICC intraclass 
correlation coefficient, AUC area under the curve. 
Assessment of the measurement properties of instruments 
The predefined quality criteria for rating the measurement properties of instruments 
recommended by the COnsensus-based Standards for the selection of health Measurement 
INstruments (COSMIN) group will be used to assess the measurement properties of the 
measures [20] (Table 1). These relate to the following measurement properties and aspects of 
measurement properties: reliability (internal consistency, measurement error, reliability), 
validity (content validity, structural validity, hypothesis testing) and responsiveness. In 
addition, we will consider whether the development of any instrument included in the 
systematic review was based on an a priori conceptual framework/model. 
Assessment of the methodological quality of included studies 
The COSMIN checklist [21-23] will be used to evaluate the methodological quality of 
included studies. In the COSMIN checklist (cf www.cosmin.nl), four domains are 
distinguished (reliability, validity, responsiveness and interpretability) with related 
measurement properties and aspects of measurement properties. For each of the measurement 
properties, the COSMIN checklist consists of 5–18 items covering methodological standards 
(organized in nine boxes for the nine measurement properties). In addition, each item can be 
scored on a four-point scale (i.e. ‘poor’, ‘fair’, ‘good’, ‘excellent’). Taking the lowest rating 
for each item in one box, an overall quality score (poor, fair, good, excellent) is obtained for 
each measurement property separately. 
Best evidence synthesis 
If several studies exist for one measure, findings will be synthesized by combining them, 
based on number and methodological quality of the studies and consistency of results as 
previously suggested [24]. The criteria for synthesizing evidence are summarized in Table 2. 
Table 2 Levels of evidence for the overall quality of a measurement property 
Level Rating Criteria 
Strong +++ or −−− Consistent findings in multiple studies of good methodological 
quality OR in one study of excellent methodological quality 
Moderate ++ or −− Consistent findings in multiple studies of fair methodological 
quality OR in one study of good methodological quality 
Limited + or − One study of fair methodological quality 
Conflicting +/− Conflicting findings 
Unknown ? Only studies of poor methological quality 
Plus sign indicates positive rating; question mark, indeterminate rating and minus sign, 
negative rating. 
Discussion 
The proposed systematic review will produce a comprehensive assessment of measurement 
properties of existing measures of asthma-specific health-related quality of life. We will 
highlight the major findings of the review and describe evidence in terms of grade supporting 
or not supporting the use of any given asthma-specific HRQL tool. We will highlight 
problems and limitations that we will find across the reviewed tools. The strengths and 
limitations in the identified evidence (e.g. relating to amount of evidence, validity, feasibility) 
will be presented and discussed. Finally, we will report about strengths and limitations of our 
review and highlight future research and policy implications. 
We also aim to derive recommendations in order to help researchers and practitioners alike in 
the choice of instrument. For each instrument identified in the review, a standardized 
recommendation for usage or required future validation work will be made depending on the 
best evidence synthesis. 
Four categories of recommendation will be made as follows: 
a) Outcome measure achieves positive ratings (at least ‘+’) for all measurement properties 
and is recommended for use. 
 
b) Outcome measure achieves positive ratings (at least ‘+’) for at least two measurement 
properties, but performance in all other required measurement properties is unclear, so that 
the outcome measure has the potential to be recommended in the future depending on the 
results of further validation studies. 
 
c) Outcome measure has low quality in at least one measurement property (at least one 
““rating) and therefore is not recommended to be used any more. 
 
d) Outcome measure has (almost) not been validated. Its performance in all or most relevant 
measurement properties is unclear, so that it is not recommended to be used until further 
validation studies clarify its quality. 
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